Tarang Amin

CEO, President, Chairman of the Board at elf Beauty Inc

Board

Since January 2014

Age

59 years

Education

Holds a B.A. in International Policy and an M.B.A. from Duke University.

Tenure

Joined e.l.f. Beauty in January 2014 as CEO, was promoted to Chairman in August 2015 and to President in March 2019.

Also at elf Beauty Inc

Jennie Laar

Senior Vice President and Chief Commercial Officer

Josh Franks

Senior Vice President and COO

Kory Marchisotto

Senior Vice President and Chief Marketing Officer

About

Tarang Amin is a 59-year-old executive of Indian descent, born in East Africa, whose early experiences instilled in him the value of resilience and entrepreneurship. His formative years and diverse background have helped shape his distinctive approach to leadership and innovation in the retail and consumer products sectors.

With over 30 years of experience in consumer brands, he launched his career at Procter & Gamble, where he contributed to the transformation of Pantene into a global market leader, and later held significant roles at The Clorox Company and Schiff Nutrition, Inc. His career is a testament to his expertise in driving growth and managing strategic business units.

At e.l.f. Beauty, his journey began in January 2014 when he took on the role of CEO. He quickly expanded his influence by becoming Chairman of the Board in August 2015 and President in March 2019, spearheading initiatives that have led to consistent growth and market share gains.

Beyond his role at e.l.f. Beauty, his broader professional contributions include service on public company boards, and his deep industry knowledge continues to drive innovative strategies across the consumer products landscape.

$ELF Performance Under Tarang Amin

Past Roles

Organization	Role	Date Range	Details
The Clorox Company	Vice President, General Manager of Litter, Food, and Charcoal Strategic Business Units	April 2008 - March 2013	Multinational consumer products company
Schiff Nutrition, Inc.	President and Chief Executive Officer	March 2011 - January 2013	Ended with company acquisition

External Roles

Organization	Role	Date Range	Details
The J.M. Smucker Co.	Board of Directors	Since August 2023	N/A
Pharmavite LLC	Board of Directors	Present [N/A]	N/A

Fixed Compensation

Data from FY 2024

Component Name	Amount	Payment Schedule	Additional Details
Salary	$475,000	Annual	Base salary provided as fixed compensation
All Other Compensation	$9,500	Annual	Other forms of compensation including benefits and perquisites

Performance Compensation

Data from FY 2024

Annual Cash Incentive Compensation (Cash-Based Award)

Metric	Threshold	Target	Maximum	Actual Outcome	Payout (%)
Adjusted EBITDA (Millions)	$120.3M	$140.1M	$147.1M	$235M	200%

Payout Details: The target value is $475,000 and the actual payout received was $950,000 due to achieving 200% of the target.
Vesting Schedule: Not applicable as this is a cash-based award.
Evaluation Period: FY 2024.

Equity Incentive Awards

Performance Stock Units (PSUs) and Restricted Stock Units (RSUs)

Award Type	Grant Date	Threshold (Units)	Target (Units)	Maximum (Units)	Grant Date Fair Value	Performance Metrics	Vesting Conditions
PSUs	06/01/2023	13,140	32,851	73,915	$3,499,946	Net Sales CAGR, Adjusted EBITDA CAGR, Market Share Gain	Vest based on performance attainment; if Market Share goal not met, vest at target
RSUs	06/01/2023	N/A	32,851	N/A	$3,499,946	Time-based vesting	Vesting contingent on continued service

Evaluation Period: FY 2024 with performance measured on key metrics.
Additional Details: For the PSUs, if the performance goals are achieved at the maximum level, a higher market value may be realized. The cash incentive and equity awards are structured to align with operational performance and shareholder value creation.

All performance compensation details pertain to the metrics, targets, and outcomes for FY 2024 as available from the documents.